Author:
Tefferi Ayalew,Vannucchi Alessandro M.,Barbui Tiziano
Publisher
Springer Science and Business Media LLC
Reference79 articles.
1. Arber, D. A. et al. The2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127, 2391–2405 (2016).
2. Tefferi, A. & Pardanani, A. Myeloproliferative neoplasms: a contemporary review. JAMA Oncol. 1, 97–105 (2015).
3. Tefferi, A. Somatic JAK2 mutations and their tumor phenotypes. Blood 128, 748–749 (2016).
4. Alghasham, N., Alnouri, Y., Abalkhail, H. & Khalil, S. Detection of mutations in JAK2 exons 12-15 by Sanger sequencing. Int. J. Lab. Hematol. 38, 34–41 (2016).
5. Barbui, T., Thiele, J., Vannucchi, A. M. & Tefferi, A. Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis. Blood Cancer J. 5, e337 (2015).
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献